Molybdenum trioxide enhances viability, osteogenic differentiation and extracellular matrix formation of human bone marrow-derived mesenchymal stromal cells.

Decker, S; Kunisch, E; Moghaddam, A; Renkawitz, T; Westhauser, F

Decker, S; Kunisch, E; Moghaddam, A; Renkawitz, T; Westhauser, F.

Afiliação

Decker S; Center of Orthopedics, Traumatology, and Spinal Cord Injury, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118, Heidelberg, Germany.
Kunisch E; Center of Orthopedics, Traumatology, and Spinal Cord Injury, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118, Heidelberg, Germany.
Moghaddam A; Orthopedic and Trauma Surgery, Frohsinnstraße 12, 63739, Aschaffenburg, Germany.
Renkawitz T; Center of Orthopedics, Traumatology, and Spinal Cord Injury, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118, Heidelberg, Germany.
Westhauser F; Center of Orthopedics, Traumatology, and Spinal Cord Injury, Heidelberg University Hospital, Schlierbacher Landstraße 200a, 69118, Heidelberg, Germany. Electronic address: Fabian.Westhauser@med.uni-heidelberg.de.

J Trace Elem Med Biol ; 68: 126827, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34371328

Assuntos

Células-Tronco Mesenquimais; Molibdênio; Medula Óssea; Células da Medula Óssea; Diferenciação Celular; Células Cultivadas; Cadeia alfa 1 do Colágeno Tipo I; Matriz Extracelular; Humanos; Molibdênio/farmacologia; Osteogênese; Óxidos

Palavras-chave

Cell viability; Extracellular matrix formation; Human bone marrow derived mesenchymal stromal cells; Molybdenum; Osteogenic differentiation; Trace elements

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Mesenquimais / Molibdênio Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google